Universal Skin Impex Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 100.37%
(FY 2022)
- Profit 33.53%
(FY 2022)
- Ebitda 194.56%
(FY 2022)
- Net Worth 4.20%
(FY 2022)
- Total Assets -15.23%
(FY 2022)
About Universal Skin Impex
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vivekbhai Rami and Vatsal Rami serve as directors at the Company.
- CIN/LLPIN
U52190GJ2011PTC066565
- Company No.
066565
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Universal Skin Impex Private Limited offer?
Universal Skin Impex Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Organic Soap, Nutraceuticals & Dietary Supplements, Protein Powder, Bath Soaps, Medicated Soap.
Who are the key members and board of directors at Universal Skin Impex?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivekbhai Rami  | Director | 01-Jul-2013 | Current |
| Vatsal Rami | Director | 04-Apr-2018 | Current |
Financial Performance of Universal Skin Impex.
Universal Skin Impex Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 100.37% increase. The company also saw a substantial improvement in profitability, with a 33.53% increase in profit. The company's net worth moved up by a moderate rise of 4.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Universal Skin Impex?
In 2020, Universal Skin Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Valentis Life Science Private LimitedActive 16 years 11 monthsVivekbhai Rami and Vatsal Rami are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Universal Skin Impex?
Unlock and access historical data on people associated with Universal Skin Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Universal Skin Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Skin Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
